Drug Approval | November 02, 2023
NATCO Pharma announces successful completion of USFDA inspection
NATCO's Pharmacovigilance Department was inspected from October 30, 2023 to November 1, 2023
NATCO's Pharmacovigilance Department was inspected from October 30, 2023 to November 1, 2023
The European Commission approved the use of Carbopol as an additive for liquid and solid food supplements in the EU
2023 Nobel laureates discovered how pseudouridine could make mRNA suitable for vaccines
Dr Reddy’s Laboratories recorded revenue of Rs 6,880.20 crore during the quarter
Additional premium services in RegXcellence will include access to BASF’s Product Carbon Footprint data and direct downloads of audit reports
Orgovyx is the first and only oral GnRH receptor antagonist approved for advanced prostate cancer in Canada
Investment is additive to KKR’s existing health care growth strategy
Three block copolymers added to RESOMER portfolio of bioabsorbable polymers
Short-term treatment of heartburn and other symptoms associated with gastroesophageal reflux disease (GERD)
New effective carrier systems for drug delivery in different dosage applications including oral, topical & parenteral
Subscribe To Our Newsletter & Stay Updated
